Search Details

Word: roberte (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...Campbell avoids stocks—not his expertise, he says—and focuses on less risky assets. His conservative strategy dates back to the mid-90s, when he says he and his Yale adviser Robert J. Shiller predicted that the booming market would cool...

Author: By Noah S. Rayman and Elyssa A. L. Spitzer, CRIMSON STAFF WRITERS | Title: Economics Professors Push Safe Investing Strategies | 10/23/2009 | See Source »

...can’t simply pass a law telling the resources to go from the wealthy to the local population,” said Robert Seidman said, who, like his wife, is a professor at Boston University Law School. “Although Non-Governmental Organizations and education can facilitate improvement as well, the state is the nation’s largest employer in most of the nations in which we’ve worked,” he said. “Legislation is the clear way to enhance and solidify these changes...

Author: By Colin Whelehan, CONTRIBUTING WRITER | Title: Scholars Propose Legislation | 10/22/2009 | See Source »

...that a bill works if it actually induces the behavior it prescribes and if that effectively helps resolve the targeted social problem,” Robert Seidman said...

Author: By Colin Whelehan, CONTRIBUTING WRITER | Title: Scholars Propose Legislation | 10/22/2009 | See Source »

...were really thrilled that Robert and Ann Seidman were able to visit with us and share their insights,” Berastain said...

Author: By Colin Whelehan, CONTRIBUTING WRITER | Title: Scholars Propose Legislation | 10/22/2009 | See Source »

...similar approach work with biotechnology drugs, which were not dealt with in the 1984 law because the industry was then in its infancy? A 2008 analysis by former Clinton Administration official Robert Shapiro, who has consulted for both biologics companies and their would-be generic competitors, suggested that generic versions of the top 12 categories of biologics whose patents have expired or will expire soon could save Americans up to $108 billion in the first 10 years and as much as $378 billion over two decades. "It's the low-hanging fruit," says Mark Merritt, head of the Pharmaceutical Care...

Author: /time Magazine | Title: How Drug-Industry Lobbyists Won on Health-Care | 10/22/2009 | See Source »

Previous | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | Next